While generally safe, docusate is less effective than osmotic laxatives for established constipation and works best as a preventive measure or in combination with other agents
Current status As of early 2026, compounding pharmacies like Empower can continue producing semaglutide formulations that are clinically differentiated from commercially available products
Ann Emerg Med 2002, 39: 616-621
Analytical reviews of peptide materials describe mass spectrometry as useful for structural and molecular characterization, especially when paired with orthogonal methods [27]
Combination therapy is typically considered for patients with inadequate glycemic control on GLP-1 monotherapy or when cost, adherence, or side effects favor adding an oral DPP-4 rather than increasing GLP-1 dose
But the perks may extend far beyond the metabolism